Successful coronary artery bypass graft surgery in severe congenital factor VII deficiency: Perioperative treatment with factor VII concentrate

• References

• 1 Williams WJ, Ernst B, Allan JE. et al. Hematology.. 3^rd ed. New York: McGraw-Hill; 1983: 1393.
• 2 Ingerslev J, Kristensen HL. Clinical picture and treatment strategies in factor VII deficiency.. Haemophilia 1998; 4: 689-696.
• 3 Engoren MC, Habib RH, Zacharias A. et al. Effect of blood transfusion on long-term survival after cardiac operation.. Ann Thorac Surg 2002; 74: 1180-1186.
• 4 Habib RH, Zacharias A, Schwann TA. et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome.. Crit Care Med 2005; 33: 1749-1756.
• 5 Giansily-Blaizot M, Biron-Andreani C, Aguilar-Martinez P. et al. Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding.. Br J Haematol 2002; 117: 172-175.
• 6 Giansily-Blaizot M, Schved JF. Potential predictors of bleeding risk in inherited factorVII deficiency. Clinical, biological and molecular criteria.. Thromb Haemost 2005; 94: 901-906.
• 7 Triplett DA, Brandt JT, Batard MA. et al. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis.. Blood 1985; 66: 1284-1287.
• 8 Yorke AJ, Mant MJ. Factor VII deficiency and surgery.. Is preoperative replacement therapy necessary? JAMA 1977; 238: 424-425.
• 9 Mariani G, Herrmann FH, Dolce A. et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency.. Thromb Haemost 2005; 93: 481-487.
• 10 Kelleher Jr JF, Gomperts E, Davis W. et al. Selection of replacement therapy for patients with severe factor VII deficiency.. Am J Pediatr Hematol Oncol 1986; 8: 318-323.
• 11 Cartmill TB, Castaldi PA, Halliday EJ. Cardiacvalve surgery in factor-VII deficiency.. Lancet 1968; 1: 752-753.
• 12 Ferster A, Capouet V, Deville A. et al. Cardiac surgery with extracorporeal circulation in severe factor VII deficiency.. Haemostasis 1993; 23: 65-68.
• 13 Gagliardi C, D’Avino R, Stassano P. et al. Open heart surgery with factor VII deficiency.. J Cardiovasc Surg (Torino) 1983; 24: 172-174.
• 14 Tokunaga C, Hiramatsu Y, Horigome H. et al. Palliative open heart surgery in an infant with factor VII deficiency.. Ann Thorac Surg 2003; 76: 2093-2094.
• 15 Elsner J, Kalweit G, Frehen D. et al. Substitution therapy of congenital factor VII deficiency at an extended operation with extracorporeal circulation.. Eur J Cardiothorac Surg 1999; 16: 387-388.
• 16 Charpiat B, Laporte S, Mismetti P. et al. Perioperative pharmacokinetics of factor VII concentrate during liver surgery in a patient with congenital factor VII deficiency: an individual mathematical model.. Blood Coagul Fibrinolysis 2002; 13: 457-460.
• 17 Bech RM. Recombinant factor VIIa in joint and muscle bleeding episodes.. Haemostasis 1996; 26 (Suppl. 01) 135-138.
• 18 Franchini M, Zaffanello M, Veneri D. Recombinant factor VIIa. An update on its clinical use.. Thromb Haemost 2005; 93: 1027-1035.
• 19 Schulman S, Tjonnfjord GE. et al. Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.. Thromb Haemost 2005; 94: 1177-1180.
• 20 Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.. Haemophilia 2006; 12: 19-27.
• 21 Hoffman M, Monroe DM III. A cell-based model of hemostasis.. Thromb Haemost 2001; 85: 958-965.